Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 10/20 | 0.41 |
| ▸ | PDK1 | Q15118 | 1/20 | 0.41 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.41 |
| ▸ | PDK3 | Q15120 | 1/20 | 0.41 |
| ▸ | PDK4 | Q16654 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 4/20 | 0.40 |
| ▸ | EPHX2 | P34913 | 3/20 | 0.40 |
| ▸ | NPC1 | O15118 | 3/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.35 |
| ▸ | CA12 | O43570 | 1/20 | 0.34 |
| ▸ | CA1 | P00915 | 1/20 | 0.34 |
| ▸ | CA2 | P00918 | 1/20 | 0.34 |
| ▸ | MMP2 | P08253 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27746258 | 1.00 | EPHX1 (0.41) | EPHX1PDK1PDK2PDK3PDK4 | |
| SCHEMBL28626663 | 0.94 | EPHX1 (0.34) | EPHX1PDK1PDK2PDK3PDK4 | |
| SCHEMBL27716512 | 0.90 | PKM (0.36) | — | |
| SCHEMBL10950148 | 0.80 | EPHX1 (0.41) | EPHX1RAB9AEPHX2NPC1SMN1; SMN2 | |
| SCHEMBL27805832 | 0.80 | GAA (0.42) | EPHX1PDK1PDK2PDK3PDK4 | |
| SCHEMBL14738908 | 0.79 | CCR2 (0.32) | EPHX1EPHX2 | |
| Ammonia Solution, Strong SCHEMBL28219804 | 0.78 | GAA (0.41) | EPHX1PDK1PDK2PDK3PDK4 | |
| SCHEMBL4114063 | 0.78 | PDK1 (0.36) | EPHX1PDK1PDK2PDK3PDK4 | |
| Water SCHEMBL28072177 | 0.78 | GAA (0.41) | EPHX1PDK1PDK2PDK3PDK4 | |
| SCHEMBL7291838 | 0.77 | EPHX2 (0.32) | EPHX2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8633175-B2 | Compounds as antagonists or inverse agonists at opioid receptors | GLAXOSMITHKLINE LLC (US) | 2014-01-21 | — | — | US | disclosed |
| CN-103492370-A | Substituted diaminocarboxamides and diaminocarbonitrile pyrimidines, compositions thereof, and methods of treatment therewith | SIGNAL PHARM LLC | 2014-01-01 | — | — | CN | disclosed |
| CN-102753522-B | Substituted pyrrolidine-2-carboxamides | HOFFMANN LA ROCHE | 2013-11-27 | — | — | CN | disclosed |
| CN-102753522-A | Substituted pyrrolidine-2-carboxamides | HOFFMANN LA ROCHE | 2012-10-24 | — | — | CN | disclosed |
| CN-102159207-A | Substituted pyrrolidine-2-carboxamides | HOFFMANN LA ROCHE | 2011-08-17 | — | — | CN | disclosed |
| US-20110124559-A1 | NOVEL COMPOUNDS AS ANTAGONISTS OR INVERSE AGONISTS AT OPIOID RECEPTORS | SMITHKLINE BEECHAM CORPORATION (US) | 2011-05-26 | — | — | US | disclosed |
| CN-100343304-C | Hydrolytically stable maleimide-terminated polymers | NEKTAR THERAPEUTICS AL CORP (US) | 2007-10-17 | — | — | CN | disclosed |
| CN-1732206-A | Hydrolytically stable maleimide-terminated polymers | NEKTAR THERAPEUTICS AL CORP (US) | 2006-02-08 | — | — | CN | disclosed |
| US-4048228-A | Substituted cyanamidic compounds | UOP INC. (US) | 1977-09-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110124559-A1 | NOVEL COMPOUNDS AS ANTAGONISTS OR INVERSE AGONISTS AT OPIOID RECEPTORS | OPRL1, OPRM1, OPRK1 | EPHX1 1978/4885PDK1 4364/4885PDK2 4021/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.